INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 729 | -98.3% | 0.00% | – |
| Q1 2022 | $48,000 | -48.9% | 41,729 | 0.0% | 0.00% | – |
| Q4 2021 | $94,000 | -34.3% | 41,729 | -0.5% | 0.00% | – |
| Q3 2021 | $143,000 | -36.2% | 41,936 | -44.1% | 0.00% | – |
| Q2 2021 | $224,000 | +54.5% | 75,000 | +67.4% | 0.00% | – |
| Q1 2017 | $145,000 | +141.7% | 44,801 | +0.0% | 0.00% | – |
| Q4 2016 | $60,000 | -14.3% | 44,800 | 0.0% | 0.00% | – |
| Q3 2016 | $70,000 | +16.7% | 44,800 | 0.0% | 0.00% | – |
| Q2 2016 | $60,000 | -74.6% | 44,800 | 0.0% | 0.00% | – |
| Q1 2016 | $236,000 | -33.0% | 44,800 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $352,000 | -7.1% | 44,800 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $379,000 | -34.8% | 44,800 | -15.6% | 0.00% | 0.0% |
| Q2 2015 | $581,000 | +98.3% | 53,082 | +153.4% | 0.00% | – |
| Q1 2015 | $293,000 | – | 20,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |